为什么需要估计来定义临床试验中的治疗效果?
Oliver N Keene1, Helle Lynggaard2, Stefan Englert3
1KeeneONStatistics, Maidenhead, UK. oliverkeene405@gmail.com.
BMC medicine
|July 27, 2023
概括
估计框架通过精确定义治疗效应,提高了临床试验的清晰度. 这种方法提供了比传统的治疗意图 (ITT) 或每条协议分析更全面的视角.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 基于证据的医学基于证据的医学.
背景情况:
- 传统的临床试验分析,如意图治疗 (ITT) 和每条协议都有局限性.
- 这些方法不能完全解决特定的临床问题,例如没有救援药物的治疗效果.
- 现有的分析无法捕捉对某些研究情景至关重要的细微治疗效果定义.
研究的目的:
- 在临床试验中引入和倡导估计和框架.
- 突出当前分析方法 (ITT,每协议) 在解决复杂的临床问题的局限性.
- 强调需要更精确地定义治疗效应的必要性.
主要方法:
- 该研究讨论了估计的概念,作为治疗效应的精确定义.
- 它将估计方法与传统的ITT和每个协议分析进行对比.
- 文本解释了估计如何解释治疗后的事件,如药物使用或停药.
主要成果:
- 估计和框架为治疗效果提供了更广泛的视角.
- 它允许在各种假设场景下定义治疗效应,例如没有救援药物.
- 估计提供了更细致的了解,后启动事件如何影响治疗效果的解释.
结论:
- 估计和框架显著提高了临床试验的清晰度和透明度.
- 当前具有影响力的指导方针 (Cochrane,CONSORT) 没有充分反映估计的重要性.
- 建议对现有的临床试验报告准则进行修订,以纳入估计方法和方法.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
11:51Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.2K
相关概念视频
What are Estimates?
5.3K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates.
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
5.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Kaplan-Meier Approach
182
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
182
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
